Madrigal Pharmaceuticals Stock Forward View - Double Exponential Smoothing
| MDGL Stock | USD 494.69 1.85 0.37% |
Madrigal Stock outlook is based on your current time horizon. Although Madrigal Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Madrigal Pharmaceuticals' systematic risk associated with finding meaningful patterns of Madrigal Pharmaceuticals fundamentals over time.
As of now, the RSI of Madrigal Pharmaceuticals' share price is approaching 47. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Madrigal Pharmaceuticals, making its price go up or down. Momentum 47
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (1.87) | EPS Estimate Current Year (10.86) | EPS Estimate Next Year 1.6898 | Wall Street Target Price 657.1333 | EPS Estimate Current Quarter (1.99) |
Using Madrigal Pharmaceuticals hype-based prediction, you can estimate the value of Madrigal Pharmaceuticals from the perspective of Madrigal Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Madrigal Pharmaceuticals using Madrigal Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Madrigal using crowd psychology based on the activity and movement of Madrigal Pharmaceuticals' stock price.
Madrigal Pharmaceuticals Short Interest
An investor who is long Madrigal Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Madrigal Pharmaceuticals and may potentially protect profits, hedge Madrigal Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 408.3497 | Short Percent 0.1963 | Short Ratio 11.44 | Shares Short Prior Month 3.7 M | 50 Day MA 554.2372 |
Madrigal Relative Strength Index
The Double Exponential Smoothing forecasted value of Madrigal Pharmaceuticals on the next trading day is expected to be 492.40 with a mean absolute deviation of 11.94 and the sum of the absolute errors of 716.28.Madrigal Pharmaceuticals Hype to Price Pattern
Investor biases related to Madrigal Pharmaceuticals' public news can be used to forecast risks associated with an investment in Madrigal. The trend in average sentiment can be used to explain how an investor holding Madrigal can time the market purely based on public headlines and social activities around Madrigal Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Madrigal Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Madrigal Pharmaceuticals.
Madrigal Pharmaceuticals Implied Volatility | 0.56 |
Madrigal Pharmaceuticals' implied volatility exposes the market's sentiment of Madrigal Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Madrigal Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Madrigal Pharmaceuticals stock will not fluctuate a lot when Madrigal Pharmaceuticals' options are near their expiration.
The Double Exponential Smoothing forecasted value of Madrigal Pharmaceuticals on the next trading day is expected to be 492.40 with a mean absolute deviation of 11.94 and the sum of the absolute errors of 716.28. Madrigal Pharmaceuticals after-hype prediction price | USD 494.69 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Madrigal Pharmaceuticals to cross-verify your projections. Prediction based on Rule 16 of the current Madrigal contract
Based on the Rule 16, the options market is currently suggesting that Madrigal Pharmaceuticals will have an average daily up or down price movement of about 0.035% per day over the life of the 2026-04-17 option contract. With Madrigal Pharmaceuticals trading at USD 494.69, that is roughly USD 0.17 . If you think that the market is fully incorporating Madrigal Pharmaceuticals' daily price movement you should consider acquiring Madrigal Pharmaceuticals options at the current volatility level of 0.56%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Madrigal Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Madrigal Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Madrigal Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Madrigal Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Madrigal Pharmaceuticals' open interest, investors have to compare it to Madrigal Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Madrigal Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Madrigal. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Madrigal Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Madrigal price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Madrigal using various technical indicators. When you analyze Madrigal charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Madrigal Pharmaceuticals Double Exponential Smoothing Price Forecast For the 31st of January
Given 90 days horizon, the Double Exponential Smoothing forecasted value of Madrigal Pharmaceuticals on the next trading day is expected to be 492.40 with a mean absolute deviation of 11.94, mean absolute percentage error of 277.30, and the sum of the absolute errors of 716.28.Please note that although there have been many attempts to predict Madrigal Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Madrigal Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Madrigal Pharmaceuticals Stock Forecast Pattern
| Backtest Madrigal Pharmaceuticals | Madrigal Pharmaceuticals Price Prediction | Buy or Sell Advice |
Madrigal Pharmaceuticals Forecasted Value
In the context of forecasting Madrigal Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Madrigal Pharmaceuticals' downside and upside margins for the forecasting period are 489.29 and 495.50, respectively. We have considered Madrigal Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Madrigal Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Madrigal Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.7476 |
| MAD | Mean absolute deviation | 11.938 |
| MAPE | Mean absolute percentage error | 0.0223 |
| SAE | Sum of the absolute errors | 716.2779 |
Predictive Modules for Madrigal Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Madrigal Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Madrigal Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Madrigal Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Madrigal Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Madrigal Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Madrigal Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Madrigal Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Madrigal Pharmaceuticals' historical news coverage. Madrigal Pharmaceuticals' after-hype downside and upside margins for the prediction period are 491.60 and 497.78, respectively. We have considered Madrigal Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Madrigal Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Madrigal Pharmaceuticals is based on 3 months time horizon.
Madrigal Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Madrigal Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Madrigal Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Madrigal Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.35 | 3.11 | 0.64 | 0.35 | 2 Events / Month | 6 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
494.69 | 494.69 | 0.00 |
|
Madrigal Pharmaceuticals Hype Timeline
Madrigal Pharmaceuticals is now traded for 494.69. The entity has historical hype elasticity of 0.64, and average elasticity to hype of competition of 0.35. Madrigal is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is about 169.02%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.35%. %. The volatility of related hype on Madrigal Pharmaceuticals is about 313.82%, with the expected price after the next announcement by competition of 495.04. About 92.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 12.91. Madrigal Pharmaceuticals last dividend was issued on the 25th of July 2016. The entity had 1:35 split on the 25th of July 2016. Given the investment horizon of 90 days the next forecasted press release will be in a few days. Check out Historical Fundamental Analysis of Madrigal Pharmaceuticals to cross-verify your projections.Madrigal Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Madrigal Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Madrigal Pharmaceuticals' future price movements. Getting to know how Madrigal Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Madrigal Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RNA | Avidity Biosciences | 0.06 | 9 per month | 0.00 | 0.12 | 0.91 | (0.34) | 42.94 | |
| JAZZ | Jazz Pharmaceuticals PLC | 0.53 | 9 per month | 1.71 | 0.08 | 3.66 | (3.14) | 25.96 | |
| MRNA | Moderna | 6.31 | 9 per month | 3.82 | 0.17 | 10.85 | (7.01) | 23.11 | |
| CAI | Caris Life Sciences | 0.04 | 13 per month | 0.00 | (0.08) | 4.33 | (4.27) | 21.66 | |
| RYTM | Rhythm Pharmaceuticals | 0.04 | 10 per month | 0.00 | (0.03) | 4.03 | (5.14) | 18.69 | |
| ABVX | Abivax SA American | 0.83 | 8 per month | 3.44 | 0.08 | 6.94 | (6.09) | 29.38 | |
| TECH | Bio Techne Corp | (0.10) | 6 per month | 1.75 | (0.02) | 3.72 | (2.93) | 8.09 | |
| EXEL | Exelixis | 1.84 | 2 per month | 1.71 | 0.04 | 4.06 | (2.93) | 11.45 | |
| BMRN | Biomarin Pharmaceutical | 0.18 | 9 per month | 1.70 | 0.02 | 3.20 | (3.05) | 22.06 | |
| BAX | Baxter International | 0.18 | 13 per month | 0.00 | (0.1) | 2.82 | (3.63) | 15.20 |
Other Forecasting Options for Madrigal Pharmaceuticals
For every potential investor in Madrigal, whether a beginner or expert, Madrigal Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Madrigal Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Madrigal. Basic forecasting techniques help filter out the noise by identifying Madrigal Pharmaceuticals' price trends.Madrigal Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Madrigal Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Madrigal Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Madrigal Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Madrigal Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Madrigal Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Madrigal Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Madrigal Pharmaceuticals stock market strength indicators, traders can identify Madrigal Pharmaceuticals entry and exit signals to maximize returns.
Madrigal Pharmaceuticals Risk Indicators
The analysis of Madrigal Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Madrigal Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting madrigal stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.16 | |||
| Semi Deviation | 2.05 | |||
| Standard Deviation | 3.03 | |||
| Variance | 9.17 | |||
| Downside Variance | 5.27 | |||
| Semi Variance | 4.19 | |||
| Expected Short fall | (2.64) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Madrigal Pharmaceuticals
The number of cover stories for Madrigal Pharmaceuticals depends on current market conditions and Madrigal Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Madrigal Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Madrigal Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Madrigal Pharmaceuticals Short Properties
Madrigal Pharmaceuticals' future price predictability will typically decrease when Madrigal Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Madrigal Pharmaceuticals often depends not only on the future outlook of the potential Madrigal Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Madrigal Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21.3 M | |
| Cash And Short Term Investments | 926.3 M |
Check out Historical Fundamental Analysis of Madrigal Pharmaceuticals to cross-verify your projections. For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Madrigal Pharmaceuticals. Expected growth trajectory for Madrigal significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Madrigal Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (12.91) | Revenue Per Share | Quarterly Revenue Growth 3.62 | Return On Assets | Return On Equity |
Investors evaluate Madrigal Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Madrigal Pharmaceuticals' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Madrigal Pharmaceuticals' market price to deviate significantly from intrinsic value.
Understanding that Madrigal Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Madrigal Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Madrigal Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.